JUL 11, 2020 11:19 AM PDT

Predicting a Heart Attack's Prognosis with Biomarkers

WRITTEN BY: Jasper Cantrell

Biomarker studies have taken the diagnostic field by storm these past few decades. Many diseases will have unique genetic, chemical, or protein profiles. With enough research, these profiles could diagnose one or more diseases with a straightforward blood test.

Cardiac biomarkers have been around since the 1970s and are used to get a patient’s diagnosis or prognosis. With either, a patient’s mortality risk goes down considerably. Not every cardiovascular disease can be treated the same way, so it is imperative for testing to advance.

ST-segment elevation myocardial infarction (STEMI) is a type of heart attack. Considering the sudden nature of most heart attacks, it has a high mortality rate. Biomarkers of congestion and inflammation have proven helpful in diagnostic tests but remain imperfect. A team from the Universidade de Pernambuco in Brazil sought to study the cardiac biomarker carbohydrate antigen 125 (CA125). CA125’s association with heart failure is already known, but its role in STEMI is still unknown.

The team began by collecting data from a group of patients who were admitted with STEMI. They used two other leading biomarkers for STEMI prognosis, NTproBNP, and hs-CRP, to compare CA125’s results.

The data showed that age, congestion, and heart rate all corresponded to poor prognostic outlook. Focusing on CA125, there was a clear correlation with mortality. Patients admitted to the hospital with high CA125 levels had a higher risk of mortality after six months. CA125 performed similarly to NTproBNP and hs-CRP, inferring inflammation and congestion biomarkers as a whole may have prognostic significance.

This study confirmed CA125’s importance in STEMI prognosis. While it did not outperform either of the other biomarkers, it did perform as well. Patients with higher CA125 levels were more likely to have a poor prognosis. Future studies may find CA125, alongside several other markers, could create a far more powerful diagnostic tool. The better the diagnostic tool, the better the chances patients will have.

The team concludes, “This study suggests that elevated CA125 levels might be used to identify patients with STEMI with a higher risk of death at 6 months. CA125 seems to be a similar predictor of mortality compared to NTproBNP and hs-CRP.”

Sources: Nature Scientific Reports, MassGeneralHospital

About the Author
Bachelors of the Sciences
Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
MAR 10, 2022
Cardiology
COVID-19 and the Heart- Insights from Cardiac Imaging
MAR 10, 2022
COVID-19 and the Heart- Insights from Cardiac Imaging
Although widespread disease prevention strategies such as vaccination have proven significantly helpful in reducing COVI ...
MAR 18, 2022
Clinical & Molecular DX
Study Indicates Possible Links between Suicide and Undiagnosed Autism
MAR 18, 2022
Study Indicates Possible Links between Suicide and Undiagnosed Autism
The American Foundation for Suicide Prevention reports that over 45,000 Americans died by suicide in 2020, mak ...
APR 11, 2022
Technology
AI Accurately Predicts if Someone Will Die of Cardiac Arrest
APR 11, 2022
AI Accurately Predicts if Someone Will Die of Cardiac Arrest
Cardiac arrest occurs when the heart suddenly stops working, usually leading to the inability to breathe or a loss of co ...
APR 26, 2022
Cardiology
Another Study Shows Alcohol Is Bad for the Heart
APR 26, 2022
Another Study Shows Alcohol Is Bad for the Heart
Several recent studies have shown that any amount of alcohol consumption raises cardiovascular disease risk.
JUN 09, 2022
Cardiology
Supplements and Heart Health
JUN 09, 2022
Supplements and Heart Health
There is little evidence that supplements actually improve heart health.
AUG 06, 2022
Technology
Wearable Devices More Cost Effective Way to Screen for Atrial Fibrillation
AUG 06, 2022
Wearable Devices More Cost Effective Way to Screen for Atrial Fibrillation
Atrial fibrillation (AF), a condition characterized by abnormal, fast heart beats, affects an estimated five million peo ...
Loading Comments...